Cargando…
The anorexic hormone Peptide YY(3–36) is rapidly metabolized to inactive Peptide YY(3–34) in vivo
Peptide YY (PYY) is a 36 amino acid peptide hormone released from enteroendocrine cells. An N-terminally degraded metabolite, PYY(3–36,) has anorexigenic effects, which makes the PYY system a target for obesity treatment. However, little is known about the kinetics and degradation products of PYY. A...
Autores principales: | Toräng, Signe, Veedfald, Simon, Rosenkilde, Mette Marie, Hartmann, Bolette, Holst, Jens Juul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552532/ https://www.ncbi.nlm.nih.gov/pubmed/26197931 http://dx.doi.org/10.14814/phy2.12455 |
Ejemplares similares
-
Peptide YY(3–36) concentration in acute- and long-term recovered anorexia nervosa
por: Tam, Friederike I., et al.
Publicado: (2020) -
Prolonged lipopolysaccharide‐induced illness elevates glucagon‐like peptide‐1 and suppresses peptide YY: A human‐randomized cross‐over trial
por: Brodersen, Katrine, et al.
Publicado: (2022) -
The role of peptide YY in gastrointestinal diseases and
disorders
por: EL-SALHY, MAGDY, et al.
Publicado: (2013) -
Acute effects of glucagon‐like peptide‐1, GLP‐1(9–36 amide), and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers
por: Bremholm, Lasse, et al.
Publicado: (2017) -
Combination of Peptide YY(3–36) with GLP-1(7–36 amide) Causes an Increase in First-Phase Insulin Secretion after IV Glucose
por: Tan, Tricia M., et al.
Publicado: (2014)